Compositions and methods for the treatment of leukemia
OwnerRichard Rosenbloominventor
Life of this patent
Estimating the term…
Abstract
A method for the treatment of leukemia by internal administration of a composition including one or more compounds that inhibit cytokines and one or more antioxidants, optionally formulated in a pharmaceutically acceptable carrier. The composition of the present invention may further include optional ingredients such as flavonoids, flavonoid derivatives, and compounds that regulate cell differentiation and/or cell proliferation. A method for the internal administration of a composition for the purpose of treating leukemia involves the administration of an effective amount of a composition including one or more compounds that inhibit cytokines and one or more antioxidants to a person who has leukemia. Compositions useful in the method are also disclosed.
Claims20
A method for the treatment of leukemia comprising the step of internally administering to a human with leukemia, a composition which comprises an amount of one or more compounds selected from the group consisting of curcumin (diferuloylmethane), desmethoxycurcumin (hydroxycinnamoyl feruloylmethane), and bis-desmethoxycurcumin (dihydroxydicinnamoyl methane), which is effective, when administered internally, to inhibit at least one cytokine, and an effective amount of one or more antioxidants selected from the group consisting of ascorbic acid, dehydroascorbic acid, ascorbic acid esters, Ester-C® vitamin C nutritional supplement, vitamin A, esters of vitamin A, vitamin E, esters of vitamin E, α-lipoic acid, carotenoids, chlorophyllin, coenzyme Q10, glutathione, green tea polyphenols, glutathione, galangin, rutin, luteolin, morin, fisetin, silymarin, apigenin, gingkolides, hesperitin, cyanidin, citrin, aldonic acids, aldono-lactones, aldono-lactides, pharmaceutically acceptable salts of each of the foregoing antioxidants, superoxide dismutase catalase, glutathione peroxidase and methionine reductase.
A composition for the treatment of leukemia comprising about 1 to about 1000 mg of curcuminoids, an amount of chlorophyllin present in about 1 to about 540 mg of sodium copper chlorophyllin, and about 1 to about 1000 mg of alpha lipoic acid.
A composition for the treatment of leukemia comprising about 5 to about 200 mg of curcuminoids, an amount of chlorophyllin present in about 50 to about 500 mg of sodium copper chlorophyllin, and about 50 to about 300 mg of alpha lipoic acid.
A composition for the treatment of leukemia comprising about 25 to about 75 mg of curcuminoids, an amount of chlorophyllin present in about 100 to about 300 mg of sodium copper chlorophyllin, and about 75 to about 225 mg of alpha lipoic acid.
Dependencies are inferred from the claim text.